Success Metrics

Clinical Success Rate
91.7%

Based on 133 completed trials

Completion Rate
92%(133/145)
Active Trials
25(12%)
Results Posted
19%(25 trials)
Terminated
12(6%)

Phase Distribution

Ph phase_1
15
7%
Ph not_applicable
40
18%
Ph early_phase_1
6
3%
Ph phase_2
17
8%
Ph phase_4
100
46%
Ph phase_3
32
15%

Phase Distribution

21

Early Stage

17

Mid Stage

132

Late Stage

Phase Distribution210 total trials
Early Phase 1First-in-human
6(2.9%)
Phase 1Safety & dosage
15(7.1%)
Phase 2Efficacy & side effects
17(8.1%)
Phase 3Large-scale testing
32(15.2%)
Phase 4Post-market surveillance
100(47.6%)
N/ANon-phased studies
40(19.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.7%

133 of 150 finished

Non-Completion Rate

11.3%

17 ended early

Currently Active

25

trials recruiting

Total Trials

217

all time

Status Distribution
Active(39)
Completed(133)
Terminated(17)
Other(28)

Detailed Status

Completed133
unknown28
Recruiting22
Terminated12
Not yet recruiting12
Withdrawn5

Development Timeline

Analytics

Development Status

Total Trials
217
Active
25
Success Rate
91.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 16 (2.9%)
Phase 115 (7.1%)
Phase 217 (8.1%)
Phase 332 (15.2%)
Phase 4100 (47.6%)
N/A40 (19.0%)

Trials by Status

active_not_recruiting31%
completed13361%
terminated126%
not_yet_recruiting126%
recruiting2210%
withdrawn52%
enrolling_by_invitation21%
unknown2813%

Recent Activity

Clinical Trials (217)

Showing 20 of 217 trialsScroll for more
NCT07732699Phase 4

Comparative Effectiveness of Available Treatments for Sinus and Ear Infections in Children (Acute Sinusitis)

Not Yet Recruiting
NCT03511118

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Recruiting
NCT07730814Phase 4

Comparative Effectiveness of Available Treatments for Sinus and Ear Infections in Children (Acute Otitis Media)

Not Yet Recruiting
NCT05464615Early Phase 1

Geisinger Antibiotic Allergy Pilot Program: Assess and Address

Terminated
NCT05398679Phase 4

Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis

Recruiting
NCT07647835Early Phase 1

3 vs. 5 Days of Amoxicillin for Childhood Pneumonia: An RCT

Not Yet Recruiting
NCT02707042Phase 1

Microbial, Immune, and Metabolic Perturbations by Antibiotics (MIME Study)

Completed
NCT06977841Not Applicable

Tegoprazan-Based Therapies for H. Pylori Eradication: A Randomized Controlled Trial

Completed
NCT04916951Phase 1

Oral Amoxicillin and Cephalexin PK/PD in Neonates

Completed
NCT06921213Phase 2

Comprehensive Ambulatory Antibiotics for the Treatment of Congenital Syphilis

Recruiting
NCT06823154Phase 1

The Implementation and Impact of an Allergy De-Labeling Program in the Emergency Department

Active Not Recruiting
NCT06851468Not Applicable

Keverprazan Combined With Amoxicillin for the Treatment of Helicobacter Pylori

Completed
NCT07275580Phase 4

Antibiotic Prophylaxis After Simple Tooth Extraction in Immunosuppressed Patients With Autoimmune Rheumatic Diseases

Not Yet Recruiting
NCT06131021Phase 3

Shaping the Indications for Periodontal Adjunctive Antibiotics in Dental Practice

Completed
NCT06229288Phase 3

Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Ward

Recruiting
NCT07485010Phase 2

Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial

Not Yet Recruiting
NCT06154174Not Applicable

Choline to Improve Malnutrition and Enhance Cognition

Recruiting
NCT07457385Phase 4

Congenital Syphilis Treatment Trial (CONSISTENT) in Neonates

Not Yet Recruiting
NCT06494072Phase 4

Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP

Recruiting
NCT06340724Phase 3

Banxiaxiexin Decoction Combined With Vonoprazan-Amoxicillin Dual Therapy in H. Pylori Eradication

Completed

Drug Details

Intervention Type
DRUG
Total Trials
217